|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net income | |||||
| Less: Net loss from discontinued operations, net of taxes | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Loss (gain) on disposal of assets and costs from exit and disposal activities | |||||
| Stock-based compensation | |||||
| ESOP acceleration | |||||
| Amortization of deferred financing charges | |||||
| Inventory step up related to NDS acquisition | |||||
| Fair market value adjustments to derivatives | |||||
| Equity in net income of unconsolidated affiliates | |||||
| Other operating activities | |||||
| Changes in working capital: | |||||
| Receivables | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Cash Provided by (Used in) Discontinued Operation | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Capital expenditures | |||||
| Proceeds from disposition of assets or businesses | |||||
| Acquisition, net of cash acquired | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from Term Loan Facility | |||||
| Payments on syndicated Term Loan Facility | |||||
| Proceeds from Credit Agreement | |||||
| Revolving Credit Facility | |||||
| PNC Credit Agreement | |||||
| Payments on Credit Agreement | |||||
| Revolving Credit Facility | |||||
| PNC Credit Agreement | |||||
| Proceeds from commercial loan agreement | |||||
| Debt issuance costs | |||||
| Proceeds from Equipment Financing | |||||
| Payments on Equipment Financing | |||||
| Payments on finance lease obligations | |||||
| Repurchase of common stock | |||||
| Cash dividends paid | |||||
| Proceeds from noncontrolling interest holder | |||||
| Dividends paid to noncontrolling interest holder | |||||
| Proceeds from option exercises | |||||
| Payment of withholding taxes on vesting of restricted stock units | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net change in cash | |||||
| Cash at beginning of year | |||||
| Cash and restricted cash at end of year | |||||
| Restricted Cash and Cash Equivalents | |||||
| Cash | |||||
Loading...